Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Cyclic pyrimidin-4-carboxamides as CCR2 receptor antagonists for treatment of inflammation, asthma and COPD

Cyclic pyrimidin-4-carboxamides as CCR2 receptor antagonists for treatment of inflammation, asthma and COPD

US Patent 8835440 · Granted Sep 16, 2014

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pyridine derivatives with n-linked cyclic substituents as cGAS inhibitors2025
Imidazopyrazine derivatives and the use thereof as medicament2025
Cyclic ether derivatives of pyrazolo[1,5-a]pyrimidine-3-carboxyamide2025
Cyclic ether derivatives of pyrazolo[1,5-a]pyrimidine-3-carboxyamide2025
Cyclic ether derivatives of pyrazolo[1,5-a]pyrimidine-3-carboxyamide2025
CCR2 receptor antagonists and uses thereof2025
CCR2 receptor antagonists and uses thereof2025
CCR2 receptor antagonists and uses thereof2025
CCR2 receptor antagonists and uses thereof2025
CCR2 receptor antagonists and uses thereof2025
CCR2 receptor antagonists and uses thereof2025
Lubricating compositions with decarboxylated rosin acid2024